Stericycle reported that its pending $7.2 billion sale to WM has received all necessary regulatory approvals, including in Canada, to allow the deal to move forward.
The update came in its quarterly securities filing, which showed relatively flat performance in the business during its final full quarter as a publicly traded company.
“We continue to experience revenue challenges among certain national account customers, including changes in frequency and type of service and site consolidations in North America,” said the company in the filing.
It also noted effects from Hurricanes Helene and Milton on multiple customers and communities.
“While our facilities suffered minimal damage and became fully operational shortly after the storms, we are still assessing the full impact to our customers,” said Stericycle.
The company also noted the recent opening of a new medical waste incinerator in Nevada, which is currently in testing and will begin operational waste processing in 2025.
Stericycle also disclosed further details on previously announced plans to divest its Spain and Portugal assets to Urbaser. That deal is expected to close in Q4 for $86.4 million in cash.
The company’s own sale to WM is expected to close Nov. 4.
“Stericycle expects to consummate the merger as promptly as practicable, subject to satisfaction of other customary closing conditions under the merger agreement,” the company said in its filing.
